Pharm 2 COMPREHENSIVE FINAL (incl. 26-31. 44, 45, & 48 )

Question 1

Explain the mechanisms of action of antibacterial drugs
___________
Chapter 26, objective #1

Question 2

Differentiate between bacteria that are naturally resistant and those that have acquired resistance to an antibiotic
__________
Chapter 26, objective #2

Question 3

Summarize the three general adverse effects associated with antibacterial drugs
_________
Chapter 26, objective #3

Question 4

Differentiate between narrow-spectrum and broad-spectrum antibiotics
______
Chapter 26, objective #4

Question 5

Compare the effects of the natural, broad-spectrum (extended), penicillinase-resistant, and anti-pseudomonal penicillins
_________
Chapter 26, objective #5

Question 6

Contrast the effects of first-, second-, third-, and fourth- and fifth-generation cephalosporins
______
Chapter 26, objective #6

Question 7

Apply the nursing process for patients receiving penicillins and cephalosporins
________
Chapter 26, objective #7

Question 8

Apply the nursing process for tetracyclines, including patient teaching
_______
Chapter 26, objective #8

Question 9

Summarize the nurse’s role in detecting ototoxicity and nephrotoxicity associated with the administration of aminoglycosides
_______
Chapter 26, objective #9

Question 10

Explain the importance for ordering serum aminoglycosides for peak and trough concentration levels
________
Chapter 26, objective #10

Question 11

Develop a teaching plan for a patient prescribed a fluoroquinolone (quinolone)
_______
Chapter 26, objective #11

Question 12

Contrast the nursing interventions for each of the drug categories: macrolides, tetracyclines, aminoglycosides, and fluoroquinolones
_________
Chapter 26, objective #12

Question 13

Differentiate between short-acting and intermediate-acting sulfonamides
________
Chapter 26, objective #13

Question 14

Compare the similarities and differences between the sulfonamides and sulfadiazine
________
Chapter 26, objective #14

Question 15

Explain the pharmacokinetics of the sulfonamides
_________
Chapter 26, objective #15

Question 16

Apply the nursing process to the patient taking trimethoprim-sulfamethoxazole
________
Chapter 26, objective #16

Question 17

Develop a teaching plan for a patient prescribed metronidazole
__________
Chapter 26, objective #17

Question 18

Compare the groups of drugs that are urinary antiseptics and antiinfectives
______
Chapter 48, objective #1

Question 19

Describe the side effects and adverse reactions to urinary antiseptics and antiinfectives
_______
Chapter 48, objective #2

Question 20

Differentiate the uses for a urinary analgesic, a urinary stimulant, and a urinary antispasmodic/antimuscarinic/anticholinergic
____________
Chapter 48, objective #3

Question 21

Apply the nursing process, including teaching, to nursing care of the patient receiving urinary antiseptic/antiinfective drugs
____________
Chapter 48, objective #4

Question 22

Compare first-line and second-line antitubercular drugs and give examples of each
____________
Chapter 27, objective #1

Question 23

Differentiate between the five groups of antifungal drugs – polyenes, azoles, antimetabolites, echinocandins, or antiprotozoals
____________
Chapter 27, objective #2

Question 24

Explain the uses of polyenes
____________
Chapter 27, objective #3

Question 25

Differentiate the adverse reactions of antitubercular, antifungal, and antiviral drugs ____________ Chapter 27, objective #4

Question 26

Apply the nursing process for patients taking antitubercular, antifungal, and antiviral drugs ____________ Chapter 27, objective #5

Question 27

Explain the uses of antimalarial drugs ____________ Chapter 28, objective #1

Question 28

Identify side effects and adverse reactions of antimalarial drugs ____________ Chapter 28, objective #2

Question 29

Correlate transmission with prevention in people with malaria ____________ Chapter 28, objective #3

Question 30

Apply the nursing process for the patient taking antimalarial drugs ____________ Chapter 28, objective #4

Question 31

Explain the action of anthelmintic drugs ____________ Chapter 28, objective #5

Question 32

Identify adverse reactions of anthelmintic drugs ____________ Chapter 28, objective #6

Question 33

Correlate transmission with prevention in people with helminthic infections ____________ Chapter 28, objective #7

Question 34

Apply the nursing process for people receiving anthelmintic drugs ____________ Chapter 28, objective #8

Question 35

Explain the use of peptides as an antibacterial ____________ Chapter 28, objective #9

Question 36

Summarize the side effects and adverse reactions possible with peptides ____________ Chapter 28, objective #10

Question 37

Apply the nursing process for people taking antibacterials ____________ Chapter 28, objective #11

Question 38

Describe the life cycle of the human immunodeficiency virus (HIV) and relate it to the actions of pharmacologic agents used in the treatment of HIV disease ____________ Chapter 29, objective #1

Question 39

Identify the risk factors for HIV transmission ____________ Chapter 29, objective #2

Question 40

Describe the six classifications of antiretroviral therapy and give examples of medications in each group ____________ Chapter 29, objective #3

Question 41

Explain specific issues of medication adherence to antiretroviral agents ____________ Chapter 29, objective #4

Question 42

Discuss the nurse’s role in medication management and issues of adherence ____________ Chapter 29, objective #5

Question 43

Explain prophylactic treatment for opportunistic infections ____________ Chapter 29, objective #6

Question 44

Discuss the medical management for preventing mother-to-child transmission of HIV infection during pregnancy ____________ Chapter 29, objective #7

Question 45

Discuss health care workers’ exposure risks and relate the risk and type of exposure to postexposure prophylaxis recommendations ____________ Chapter 29, objective #8

Question 46

Apply the nursing process, including teaching, to care of patients infected with HIV ____________ Chapter 29, objective #9

Question 47

Compare and contrast active and passive immunity ____________ Chapter 44, objective #1

Question 48

Compare and contrast active natural and active acquired immunity ____________ Chapter 44, objective #2

Question 49

Describe infectious diseases for which vaccines are currently available ____________ Chapter 44, objective #3

Question 50

Outline the currently recommended childhood immunization schedule ____________ Chapter 44, objective #4

Question 51

Discuss vaccines routinely administered to adults ____________ Chapter 44, objective #5

Question 52

Discuss contraindications to the administration of recommended immunizations ____________ Chapter 44, objective #6

Question 53

Explain the nursing interventions, including teaching, related to the administration of vaccines ____________ Chapter 44, objective #7

Question 54

Describe the medication groups commonly used for disorders of the eye and ear ____________ Chapter 49, objective #1

Question 55

Discuss the mechanisms of action, route, side effects and adverse reactions, and contraindications for selected drugs in each group ____________ Chapter 49, objective #2

Question 56

Describe the nursing process and teaching plans related to drugs used in treating and managing disorders of the eye and ear ____________ Chapter 49, objective #3

Question 57

Differentiate acne vulgaris, psoriasis, drug-induced dermatitis, and contact dermatitis ____________ Chapter 50, objective #1

Question 58

Describe nonpharmacologic measures used to treat mild acne vulgaris ____________ Chapter 50, objective #2

Question 59

Describe at least three drugs that can cause drug-induced dermatitis and their characteristic symptoms ____________ Chapter 50, objective #3

Question 60

Compare the topical antibacterial agents used to prevent and treat burn tissue infection ____________ Chapter 50, objective #4

Question 61

Discuss the nursing process, including teaching, related to commonly used drugs for acne vulgaris, psoriasis, and burns ____________ Chapter 50, objective #5